Evidence map›Paper›PMID 41256539›Full record

ArticlebioRxiv : the preprint server for biology2025

An Interpretable Deep Learning Framework for Biomarker Discovery in Complex Disease Survival Outcomes.

Shiyu Wan, Xinlei Mi, Fei Zou, Baiming Zou

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shiyu WanDepartment of Biostatistics, University of North Carolina at Chapel Hill.
Xinlei MiDepartment of Preventive Medicine, Northwestern University.
Fei ZouDepartment of Biostatistics, University of North Carolina at Chapel Hill.
Baiming ZouDepartment of Biostatistics, University of North Carolina at Chapel Hill.

Funding

Robust Computational and Data Analytic Tools for In-depth Understanding Postoperative Pain Mechanism with Enhanced Pain Management and Clinical Decision MakingR01LM014407 · NLM · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Baiming Zou · 2024 to 2026
$1.4M
Enhanced Machine Learning Tools for Complex Data Evaluation and Integration in Advancing Health OutcomesR01HL173044 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Baiming Zou, Fei Zou · 2025 to 2026
$1.3M
NHLBI NIH HHS R01 HL173044NLM NIH HHS R01 LM014407
6 · The paper itself

Abstract

Identification of important biomarkers associated with complex disease survival outcomes is fundamental for gaining an in-depth understanding of disease mechanisms and advancing precision medicine in conditions such as cancer and cardiovascular disorders. However, these tasks are complicated by the unique nature of time-to-event data, which captures both the occurrence and timing of clinical events. Notably, complex associations such as the non-linear and non-additive biomarker interactions and the high-dimensionality challenge conventional survival data modeling approaches. To address these difficulties, we propose SurvDNN, an enhanced deep neural network framework specifically designed for survival outcomes modeling. SurvDNN incorporates a bootstrapping-based regularization strategy to mitigate overfitting and a novel stability-driven filtering algorithm to improve model robustness. To enable interpretable biomarker discovery, we extend the Permutation-based Feature Importance Test (PermFIT) to survival settings, allowing rigorous quantification of individual biomarker contributions under complex biomarker-outcome associations. Through extensive simulations and applications to real-world datasets, SurvDNN consistently outperforms existing machine learning approaches in both biomarker identification and predictive accuracy. Our results demonstrate the potential of SurvDNN coupled with PermFIT as an interpretable, robust, and powerful tool for biomarker-driven survival modeling in complex diseases. An open-source R package implementing SurvDNN is publicly available on GitHub (https://github.com/BZou-lab/SurvDNN).

Identifiers

PMID41256539
PMCPMC12621730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.